Cepheid last week reported a 28 percent spike in first-quarter revenues driven primarily by strong sales in its clinical diagnostics business, including record sequential growth in clinical reagent sales.
By Ben Butkus
Molecular Detection said this week that it has completed a $1.5 million financing to advance commercialization of its Detect-Ready molecular diagnostic panels for detecting sepsis and gastrointestinal diseases.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Molecular diagnostic firm Molecular Detection today said that it has completed a $1.5 million financing round to advance its tests for detecting sepsis and gastrointestinal diseases.
Lucigen today announced a $2.5 million grant from the National Institutes of Health to develop metagenomic DNA libraries for the identification of new antimicrobial and other anti-infective drug candidates.